科研成果详情

题名An injectable liposome for sustained release of icariin to the treatment of acute blunt muscle injury
作者
发表日期2020-09
发表期刊JOURNAL OF PHARMACY AND PHARMACOLOGY   影响因子和分区
语种英语
原始文献类型Article
关键词icariin icariin liposome liposome muscle injury
其他关键词ISCHEMIA/REPERFUSION INJURY ; SKELETAL-MUSCLE ; IN-VITRO ; PHARMACOKINETICS ; ATHEROSCLEROSIS ; REGENERATION ; EPIMEDIUM ; RECOVERY ; COLLAGEN ; RATS
摘要Objectives Icariin, extracted from Epimedium, is a kind of flavonoid and possesses osteogenesis and antioxidant. This study aimed to evaluate the therapeutic effects of icariin liposome on acute blunt skeletal muscle injury in rats. Methods Icariin liposome was prepared by the thin-film dispersion method. After muscle injury, the corresponding treatment measures were given every day for two weeks. Recovery and mechanism of muscle injury were evaluated by QRT-PCR, HE, immunohistochemistry, malondialdehyde, superoxide dismutase and serological tests. Key findings The particle size, polydispersity index, zeta potential, encapsulation efficiency and drug loading of icariin liposomes were 171.37 +/- 38.23 nm, 0.27 +/- 0.01, -5.59 +/- 1.36 mV, 78.15 +/- 2.04% and 15.62%, respectively. The QRT-PCR showed that icariin liposome significantly promoted the expression of MHCIIB and vimentin. Through HE, immunohistochemistry, ELISA and serological tests, we found that icariin liposome effectively promoted desmin expression, reduced collagen I expression and inhibited the production of pro-inflammatory factors, including TNF-alpha and IL-6. Icariin liposome therapy significantly reduced the level of malondialdehyde and increased the activity of superoxide dismutase. Conclusions Icariin liposome has excellent therapeutic effects on acute blunt muscle injury in rats by improving immunity, repairing cytoskeleton and cellular integrity, anti-inflammation, anti-fibrosis and antioxidant stress.
资助项目National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81701928]; Zhejiang Medical and Health Science and Technology Plan Project [2017KY480]
出版者WILEY
出版地HOBOKEN
ISSN0022-3573
EISSN2042-7158
卷号72期号:9页码:1152-1164
DOI10.1111/jphp.13314
页数13
WOS类目Pharmacology & Pharmacy
WOS研究方向Pharmacology & Pharmacy
WOS记录号WOS:000541540900001
收录类别SCIE ; PUBMED ; SCOPUS
URL查看原文
PubMed ID32567690
SCOPUSEID2-s2.0-85087315580
通讯作者地址[Cai, Leyi]Department of Orthopaedics,Wenzhou Medical University Second Affiliated Hospital,Wenzhou,China ; [Cai, Leyi]Wenzhou Medical University,Wenzhou,China
Scopus学科分类Medicine (all)
引用统计
被引频次:1[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符https://kms.wmu.edu.cn/handle/3ETUA0LF/1541
专题附属第二医院
温州医科大学
通讯作者Cai, Leyi
作者单位
1.Department of Orthopaedics,Wenzhou Medical University Second Affiliated Hospital,Wenzhou,China;
2.Wenzhou Medical University,Wenzhou,China
第一作者单位附属第二医院;  温州医科大学
通讯作者单位附属第二医院;  温州医科大学
第一作者的第一单位附属第二医院
推荐引用方式
GB/T 7714
Wang, Jinwu,Zhu, Gaosheng,Wang, Xingyu,et al. An injectable liposome for sustained release of icariin to the treatment of acute blunt muscle injury[J]. JOURNAL OF PHARMACY AND PHARMACOLOGY,2020,72(9):1152-1164.
APA Wang, Jinwu., Zhu, Gaosheng., Wang, Xingyu., Cai, Jie., Xie, Linzhen., ... & Cai, Leyi. (2020). An injectable liposome for sustained release of icariin to the treatment of acute blunt muscle injury. JOURNAL OF PHARMACY AND PHARMACOLOGY, 72(9), 1152-1164.
MLA Wang, Jinwu,et al."An injectable liposome for sustained release of icariin to the treatment of acute blunt muscle injury".JOURNAL OF PHARMACY AND PHARMACOLOGY 72.9(2020):1152-1164.

条目包含的文件

条目无相关文件。
个性服务
查看访问统计
谷歌学术
谷歌学术中相似的文章
[Wang, Jinwu]的文章
[Zhu, Gaosheng]的文章
[Wang, Xingyu]的文章
百度学术
百度学术中相似的文章
[Wang, Jinwu]的文章
[Zhu, Gaosheng]的文章
[Wang, Xingyu]的文章
必应学术
必应学术中相似的文章
[Wang, Jinwu]的文章
[Zhu, Gaosheng]的文章
[Wang, Xingyu]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。